Clinical Trial Update: Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating eflornithine and/or diclofenac for sun-damaged skin in patients with an unspecified benign skin neoplasm; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Other Benign Neoplasm of Skin Unspecified

Drugs mentioned

• Diclofenac (diclofenac)
• Eflornithine (eflornithine)

Snippet

Sponsor: University of Arizona | Conditions: Other Benign Neoplasm of Skin, Unspecified | Phase 2 | Status: COMPLETED | Results posted: 2017-03-23